Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acurx Pharmaceuticals Inc
(NQ:
ACXP
)
1.870
-0.010 (-0.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Acurx Pharmaceuticals Inc
< Previous
1
2
Next >
CEO Spotlight: Acurx Pharmaceuticals in Focus with CEO David Luci Talking Potentially Transformative Phase 2b Trial, Pipeline, and Potential Near-Term Catalysts
September 13, 2021
New York, New York--(Newsfile Corp. - September 13, 2021) - Acurx Pharmaceuticals (NASDAQ: ACXP) is a clinical-stage biopharmaceutical company developing...
Via
Newsfile
Topics
Death
Derivatives
Initial Public Offering
Exposures
Death
Derivatives
Intellectual Property
Acurx Pharmaceutical’s Reaches Another Milestone With Russell Microcap Inclusion; Shares Extend August Gains (NASDAQ: ACXP)
September 03, 2021
Via
AB Newswire
Acurx Pharmaceutical’s Is Disruptive To The Antibiotics Landscape- That’s Great News For Patients With Gram-Positive Infections (NASDAQ: ACXP)
September 01, 2021
Via
AB Newswire
Acurx Pharmaceuticals Plan To Change The Antibiotics Landscape Is Simple- Make Better Drugs That Target Gram-Positive Infections
August 25, 2021
Via
AB Newswire
Acurx Pharmaceutical’s On Pace To Change The Antibiotics Landscape; Trial Data Shows 100% Sustained Clinical Cure In Treating Gram-Positive Infection CDI
August 17, 2021
Via
AB Newswire
Drug Makers Overseas Are Gaining A Competitive Advantage In The Antibiotics R&D Market; Acurx Pharmaceuticals Ibezapolstat Program Is Helping Level The Field (NASDAQ: ACXP)
August 12, 2021
Via
AB Newswire
Gram Positive Bacterial Infections Can Be Fatal; Acurx Pharmaceuticals Is One Of The Few Working To Change The Treatment Landscape (NASDAQ: ACXP)
August 09, 2021
Via
AB Newswire
Acurx Pharmaceuticals Leverages IPO Capital To Develop Most Significant Advance To Antibiotics In More Than 40 Years (NASDAQ: ACXP)
July 28, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals On Pace To Deliver The Most Important Upgrade To Antibiotics Since The 1980s (NASDAQ: ACXP)
July 15, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Post-IPO Acurx Pharmaceuticals Expects To Deliver The First Meaningful Change To Antibiotics Market Since 1980s (NASDAQ: ACXP)
July 08, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Shares 15% Higher Post-IPO; On Track To Bring A New Class Of Effective Antibiotics To Market (NASDAQ: ACXP)
June 30, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Shares Surge 31% Following Its Debut Public Offering; Low Share Count And $15 Million Presents A Compelling Investment Opportunity
June 28, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
Acurx Pharmaceuticals Draws Interest After Morning IPO; Could Deliver First Class Of New Antibiotics Since The 1980’s (Nasdaq: ACXP)
June 25, 2021
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.